alfuzosin has been researched along with Hypotension, Postural in 5 studies
alfuzosin: structure given in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "The efficacy of alfuzosin in improving lower urinary tract symptoms and relieving bladder outlet obstruction has been demonstrated in numerous short- and long-term placebo-controlled studies and large-scale open studies, involving over 16,000 patients with symptomatic benign prostatic hyperplasia (BPH)." | 8.80 | Clinical uroselectivity of alfuzosin in the treatment of benign prostatic hyperplasia. ( Kirby, RS, 1998) |
| "A significant improvement of symptoms was observed in patients treated with Alfuzosin for obstructive salivary gland diseases." | 7.76 | [Alpha-1-blockers (alfuzosin) for obstructive salivary gland diseases]. ( Guerre, A; Hartl, DM; Katz, P, 2010) |
| "The efficacy of alfuzosin in improving lower urinary tract symptoms and relieving bladder outlet obstruction has been demonstrated in numerous short- and long-term placebo-controlled studies and large-scale open studies, involving over 16,000 patients with symptomatic benign prostatic hyperplasia (BPH)." | 4.80 | Clinical uroselectivity of alfuzosin in the treatment of benign prostatic hyperplasia. ( Kirby, RS, 1998) |
| "A significant improvement of symptoms was observed in patients treated with Alfuzosin for obstructive salivary gland diseases." | 3.76 | [Alpha-1-blockers (alfuzosin) for obstructive salivary gland diseases]. ( Guerre, A; Hartl, DM; Katz, P, 2010) |
| "Alfuzosin is a new alpha 1-adrenoceptor antagonist particularly effective in the symptomatic treatment of benign prostatic hypertrophy (BPH)." | 2.67 | The effect of cimetidine on the pharmacokinetics of single oral doses of alfuzosin. ( Bianchetti, G; Desager, JP; Harvengt, C; Rosenzweig, P, 1993) |
| "dizziness and orthostatic hypotension)." | 2.40 | A meta-analysis on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction. ( Djavan, B; Marberger, M, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guerre, A | 1 |
| Hartl, DM | 1 |
| Katz, P | 1 |
| Sathyapalan, T | 1 |
| Aye, MM | 1 |
| Atkin, SL | 1 |
| Desager, JP | 1 |
| Harvengt, C | 1 |
| Bianchetti, G | 1 |
| Rosenzweig, P | 1 |
| Kirby, RS | 1 |
| Djavan, B | 1 |
| Marberger, M | 1 |
2 reviews available for alfuzosin and Hypotension, Postural
| Article | Year |
|---|---|
Clinical uroselectivity of alfuzosin in the treatment of benign prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Blood Pressure; Delayed-Action Preparations; Humans; Hypotension, Orth | 1998 |
A meta-analysis on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction.
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Controlled Clinical Trials as Topic; Dizzines | 1999 |
1 trial available for alfuzosin and Hypotension, Postural
| Article | Year |
|---|---|
The effect of cimetidine on the pharmacokinetics of single oral doses of alfuzosin.
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Adult; Cimetidine; Dose-Response Relationship, D | 1993 |
2 other studies available for alfuzosin and Hypotension, Postural
| Article | Year |
|---|---|
[Alpha-1-blockers (alfuzosin) for obstructive salivary gland diseases].
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Colic; Constriction, Pathologic; Female; Follow-Up Studie | 2010 |
Postural hypotension.
Topics: Aged; Antihypertensive Agents; Humans; Hypotension, Orthostatic; Male; Physical Examination; Quinazo | 2011 |